Japanese
English
- 有料閲覧
- Abstract 文献概要
- 1ページ目 Look Inside
- 参考文献 Reference
現在パーキンソン病治療は対症療法が主体であるが,近年の疾患修飾治療薬の開発は目覚ましいものがある。パーキンソン病発症,病変拡大に関与しているαシヌクレインに対する免疫治療の臨床試験も開始されている。本論では現在進行中のαシヌクレイン免疫治療,遺伝子治療,蛋白質注入療法,細胞移植療法などのパーキンソン病疾患修飾治療について解説する。
Abstract
Currently, treatment of Parkinson's disease aims at alleviating its symptoms. However development of disease-modifying drugs has been a remarkable advancement in recent years. Furthermore, clinical trials of immunotherapy against α-synuclein, a protein involved in the pathogenesis of and lesion expansion in Parkinson's disease, have been initiated. Here, the disease-modifying treatment for patients with Parkinson's disease including the current α-synuclein immunotherapy, gene therapy, protein injection therapy, and cell transplantation therapy, has been reviewed.
Copyright © 2017, Igaku-Shoin Ltd. All rights reserved.